Litcius/Paper detail

SUMOylation in α-Synuclein Homeostasis and Pathology

Mor Savyon, Simone Engelender

2020Frontiers in Aging Neuroscience35 citationsDOIOpen Access PDF

Abstract

The accumulation and aggregation of α-synuclein are central to Parkinson's disease (PD), yet the molecular mechanisms responsible for these events are not fully understood. Post-translational modifications of α-synuclein regulate several of its properties, including degradation, interaction with proteins and membranes, aggregation and toxicity. SUMOylation is a post-translational modification involved in various nuclear and extranuclear processes, such as subcellular protein targeting, mitochondrial fission and synaptic plasticity. Protein SUMOylation increases in response to several stressful situations, from viral infections to trauma. In this framework, an increasing amount of evidence has implicated SUMOylation in several neurodegenerative diseases, including PD. This review will discuss recent findings in the role of SUMOylation as a regulator of α-synuclein accumulation, aggregation and toxicity, and its possible implication in neurodegeneration that underlies PD.

Topics & Concepts

SUMO proteinNeurodegenerationCell biologyBiologyAlpha-synucleinProtein aggregationUbiquitinNeuroscienceRegulatorParkinson's diseaseDiseaseMedicineGeneticsPathologyGeneUbiquitin and proteasome pathwaysParkinson's Disease Mechanisms and TreatmentsEndoplasmic Reticulum Stress and Disease